The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
MicroRNAs in oligodendrocyte development and remyelination
Abstract
Oligodendrocytes are the glial cells responsible for the formation of myelin around axons of the central nervous system (CNS). Myelin is an insulating layer that allows electrical impulses to transmit quickly and efficiently along neurons. If myelin is damaged, as in chronic demyelinating disorders such as multiple sclerosis (MS), these impulses slow down. Remyelination by oligodendrocytes is often ineffective in MS, in part because of the failure of oligodendrocyte precursor cells (OPCs) to differentiate into mature, myelinating oligodendrocytes. The process of oligodendrocyte differentiation is tightly controlled by several regulatory networks involving transcription factors, intracellular signaling pathways, and extrinsic cues. Understanding the factors that regulate oligodendrocyte development is essential for the discovery of new therapeutic strategies capable of enhancing remyelination. Over the past decade, microRNAs (miRNAs) have emerged as key regulators of oligodendrocyte development, exerting effects on cell specification, proliferation, differentiation, and myelination. This article will review the role of miRNAs on oligodendrocyte biology and discuss their potential as promising therapeutic tools for remyelination.image
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, miRNAs are required for neuron growth, neurogenesis regulation, oligodendrocyte differentiation, and myelination (Ngo and Kothary 2022).”
From MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis (2025) · cites this paper as Ngo and Kothary 2022
Citations
Cites
The bHLH Transcription Factors OLIG2 and OLIG1 Couple Neuronal and Glial Subtype Specification
Zhou, Q., & Anderson, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00677-3 · Cited by 1,059 · cited 1×
“These transcription factors influence the production of OPCs, as inhibiting their expression inhibits OPC specification from NPCs (Liu et al., 2003; Zhou & Anderson, 2002).”
BackgroundTargeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles
Saint-Pol, J., Gosselet, F., Duban-Deweer, S., Pottiez, G., & Karamanos, Y. (2020) · Cells · doi:10.3390/cells9040851 · Cited by 503
MicroRNAs as Regulators of Differentiation and Cell Fate Decisions
Ivey, K. N., & Srivastava, D. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.012 · Cited by 449
Olig2 Targets Chromatin Remodelers to Enhancers to Initiate Oligodendrocyte Differentiation
Yu, Y., Chen, Y., Kim, B., Wang, H., Zhao, C., He, X., Liu, L., Liu, W., Wu, L. M. N., Mao, M., et al. (2013) · Cell · doi:10.1016/j.cell.2012.12.006 · Cited by 375
Functional Genomic Analysis of Oligodendrocyte Differentiation
Dugas, J. C., Tai, Y. C., Speed, T. P., Ngai, J., & Barres, B. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2572-06.2006 · Cited by 324
Bujalka, H., Koenning, M., Jackson, S., Perreau, V. M., Pope, B., Hay, C. M., Mitew, S., Hill, A. F., Lu, Q. R., Wegner, M., et al. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001625 · Cited by 271 · cited 18×
“Lamin B1 over- expression leads to defective subcellular localization of MBP and PLP and decreased branching of maturing oligodendrocytes in vitro.”
BackgroundInfluentialIdentification of Dynamically Regulated MicroRNA and mRNA Networks in Developing Oligodendrocytes
Lau, P., Verrier, J. D., Nielsen, J. A., Johnson, K. R., Notterpek, L., & Hudson, L. D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1932-08.2008 · Cited by 252
miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS
Wang, H., Moyano, A. L., Ma, Z., Deng, Y., Lin, Y., Zhao, C., Zhang, L., Jiang, M., He, X., Ma, Z., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.03.001 · Cited by 174
MicroRNA-23a promotes myelination in the central nervous system
Lin, S.-T., Huang, Y., Zhang, L., Heng, M. Y., Ptáček, L. J., & Fu, Y.-H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317182110 · Cited by 117
Absence of miRNA-146a Differentially Alters Microglia Function and Proteome
Martin, N. A., Hyrlov, K. H., Elkjaer, M. L., Thygesen, E. K., Wlodarczyk, A., Elbaek, K. J., Aboo, C., Okarmus, J., Benedikz, E., Reynolds, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01110 · Cited by 36
Flagged first, then by citations
Research works printed but not linked: 80
- 10.3390/cells9030711 · DOI
- 10.1186/s13287-019-1208-y · DOI
- 10.1016/j.cell.2009.01.002 · DOI · Paper page
- 10.1242/dev.050633 · DOI · Paper page
- 10.1002/glia.22406 · DOI
- 10.1002/glia.23569 · DOI
- 10.1101/gad.1519207 · DOI
- 10.1002/jnr.10565 · DOI
- 10.1523/JNEUROSCI.4962-14.2015 · DOI
- 10.1523/jneurosci.0311‐14.2014 · DOI
- 10.3390/jdb5020004 · DOI
- Faria O., 2012, MicroRNA dysregulation in multiple sclerosis, Frontiers in Genetics, 3, 311
- 10.1002/dvdy.20847 · DOI
- 10.1155/2016/5029619 · DOI
- 10.1016/j.jconrel.2015.03.005 · DOI
- 10.1016/j.neuron.2010.01.027 · DOI · Paper page
- 10.1002/ana.23860 · DOI · Paper page
- 10.1016/j.tins.2019.01.002 · DOI
- 10.1016/j.cell.2009.04.031 · DOI · Paper page
- 10.1038/srep41407 · DOI
- 10.1016/j.expneurol.2009.12.020 · DOI
- 10.1016/j.mcn.2004.06.015 · DOI
- 10.1523/JNEUROSCI.0150-08.2008 · DOI · Paper page
- 10.1158/0008-5472.CAN-08-1846 · DOI
- 10.3389/fimmu.2017.00758 · DOI
- 10.7554/elife.32021 · DOI
- 10.1002/glia.22813 · DOI
- 10.1007/s12264-013-1318-y · DOI
- 10.1074/jbc.M112.366179 · DOI
- 10.1523/JNEUROSCI.1069-12.2012 · DOI
- 10.1002/jcp.29910 · DOI
- 10.1093/brain/awn096 · DOI · Paper page
- 10.1093/nar/gkq951 · DOI
- 10.1523/JNEUROSCI.1240-15.2016 · DOI
- 10.1038/srep34503 · DOI
- 10.1371/journal.pone.0010480 · DOI · Paper page
- 10.1172/JCI94012 · DOI · Paper page
- 10.3892/ijmm.2020.4648 · DOI
- 10.1242/dmm.001065 · DOI
- 10.1016/j.tins.2010.01.007 · DOI
- 10.1242/dev.00868 · DOI
- 10.1111/ejn.13485 · DOI
- 10.1007/s12035-015-9655-7 · DOI · Paper page
- 10.1016/j.ydbio.2006.10.007 · DOI
- 10.1523/JNEUROSCI.5633-11.2012 · DOI
- 10.1016/s0896‐6273(00)80897‐1 · DOI
- 10.1007/s10571-020-00836-z · DOI
- 10.3389/fimmu.2018.00490 · DOI · Paper page
- 10.1016/j.ymthe.2018.11.016 · DOI
- 10.1007/s10158-015-0180-1 · DOI
- 10.1098/rstb.2008.2262 · DOI
- 10.3390/pharmaceutics12020186 · DOI · Paper page
- 10.1128/MCB.00339-07 · DOI
- 10.1002/glia.22606 · DOI
- Raff M. C., 1998, Cell number control and timing in animal development: The oligodendrocyte cell lineage, The International Journal of Developmental Biology, 42, 263
- 10.1002/glia.23146 · DOI
- 10.1023/A:1025747832215 · DOI · Paper page
- 10.1006/mcne.1999.0790 · DOI
- 10.1038/nature09611 · DOI
- 10.1111/jnc.13394 · DOI
- 10.1074/jbc.m113.529966 · DOI
- 10.1016/j.brainres.2008.07.085 · DOI
- 10.1038/s41385-019-0216-7 · DOI
- 10.1002/ana.21927 · DOI
- 10.3389/fnins.2018.00707 · DOI
- 10.1038/nrm2347 · DOI
- 10.1101/gad.215802 · DOI
- 10.1016/j.devcel.2006.08.011 · DOI · Paper page
- Tripathi A., 2019, Oligodendrocyte intrinsic miR‐27a controls myelination and Remyelination, Cell Reports, 29
- 10.1523/JNEUROSCI.0234-09.2009 · DOI · Paper page
- 10.1006/mcne.2002.1127 · DOI · Paper page
- 10.1111/jnc.14138 · DOI
- 10.1002/glia.23821 · DOI
- 10.1016/j.nbd.2016.01.010 · DOI
- 10.1016/j.neuroscience.2017.02.029 · DOI · Paper page
- 10.1016/j.nbd.2019.01.019 · DOI
- 10.1038/nsmb.1576 · DOI · Paper page
- 10.1016/j.neuron.2010.02.018 · DOI · Paper page
- 10.1091/mbc.e12-04-0270 · DOI
- 10.1523/JNEUROSCI.1169-10.2010 · DOI
Cited by
Sorted by citations
MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis
Asl, E. R., Hosseini, S. E., Tahmasebi, F., Bolandi, N., & Barati, S. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01578-6 · Cited by 19
Metadata
- Authors
- Ngo, C., & Kothary, R.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2022-05-10
- Volume
- 162
- Issue
- 4
- Pages
- 310-321
- ISSN
- 0022-3042
- 1471-4159
- Cited by
- 44
- References
- 10
- Language
- en
- Funders
- Canadian Institutes of Health Research (PJT‐162121)
- Multiple Sclerosis Society of Canada (EGID 3779)
- University of Ottawa
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review